comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists The Role of Glucagon-Like Peptide-1 Receptor in the Treatment of Cardiovascular-Kidney-Metabolic Syndrome Bridging the gap between GLP1-receptor

International Journal of Sport Nutrition and Exercise Metabolism, 10(4), 452-463

www.cdc.gov/chronicdisease/ resources/publications/factsheets/diabetes-prediabetes.htm

Compounded semaglutide and tirzepatide are not FDA-approved, which means they are not evaluated for safety, efficacy, or manufacturing quality

These can help patients struggling with weight gain, cravings, or metabolic slowdown

Semaglutide is an FDA-approved medication that helps control appetite and improves the body's response to insulin

Notably, this study revealed that enzymatic antioxidants like catalase, Cu/Zn-SOD, and Mn-SOD did not correlate with any of the survival parameters